Metfora Revenue and Competitors

THE PROBLEM 45% of Americans suffer from at least one chronic disease. The biological processes of chronic diseases, however, progresses over decades. In fact, patients presenting common symptoms of fatigue or dizziness may be early evidence of a serious underlying condition. However, it takes an average of 2-4 years to properly diagnose these severe diseases, preventing the early disease treatment. THE SOLUTION We have developed a test that uses metabolites in the blood, combined with artificial intelligence (AI) to quickly identify what diseases are present for earlier diagnosis and treatment. AI identifies the diseases that are present by recognizing patterns in the patient’s circulating metabolites providing a quick result to the doctor and patient. We have patented these patterns as “disease fingerprints” and are the first in the field to use such a novel approach.